Bon Natural Life Limited Class A (BON)
NASDAQ: BONHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BON stock chart
Technical analysisKey statistics
All statistics- Market cap
- $8.53M
- Forward P/E
- 1.80
- EPS (TTM)
- -$2.79
- Dividend yield
- None
- 52-week range
- 0.95 – 1.94
- Day range
- 1.03 – 1.05
- Volume / Avg
- 118.38K / 10.82K
- Beta
- —
- Shares outstanding
- 6.13M
52-week range
BON stock today
On Nov 20, BON ended the session at $1.04, shedding $0.0052 (0.50%), versus the S&P 500's 3.70% decline. Volume was 10.9x the average at 118.38K shares, a sign of unusually heavy trading. Shares are 46.1% below their 52-week high of $1.94 and 10.0% above the 52-week low of $0.95, near the bottom of the past year's range.
Bon Natural Life has posted a net loss over the last twelve months (EPS of -$2.79), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Bon Natural Life
Company profileBon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Yongwei Hu
- Headquarters
- Xi'an
- Employees
- 96
- IPO year
- 2021
- Website
- bnlus.com
Financial highlights
Full financialsIn fiscal 2025, Bon Natural Life generated $18.7 million in revenue, down 21.7% from fiscal 2024, its first annual decline since 2024. Bon Natural Life reported a net loss of $2.0 million, compared with net income of $398,172 a year earlier. Gross margin was 20.8% (down from 29.8%) and operating margin -8.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $18.67M | $23.84M | $29.52M | $29.91M | $25.49M |
| Growth | -21.70% | -19.23% | -1.29% | +17.31% | +39.93% |
| Net income | $-1.99M | $398.17K | $4.60M | $6.24M | $4.59M |
| EPS (diluted) | $-0.72 | $4.14 | $124.92 | $7.43 | $0.68 |
BON news
All BON news- BON Unveils Joint Lab for Natural Ingredients & Biomanufacturing with China Oat Group, Advancing Life Sciences InnovationPR Newswire
- Bonduelle - Combined General Meeting of December 3, 2026: Statement of availability of documentsGlobeNewswire
- Bonduelle - Assemblée générale mixte du 3 décembre 2026 : Modalités de mise à disposition des documents préparatoiresGlobeNewswire
- BONDUELLE - Déclaration mensuelle du nombre d'actions et de droits de voteGlobeNewswire
- BONDUELLE - Monthly statement of the number of shares and voting rightsGlobeNewswire
- Bonduelle - Chiffre d’affaires du 1er trimestre 2026-2027 : Dans un contexte exigeant, le Groupe Bonduelle clôture son 1er trimestre en légère croissanceGlobeNewswire
- Bonduelle - Quarter 1 FY 2026-2027 sales: Bonduelle Group delivered slight growth in the Quarter 1, in a challenging environmentGlobeNewswire
- Bonduelle - Statement of availability of 2025-2026 Universal Registration DocumentGlobeNewswire
Bon Natural Life peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AKANAkanda Corp. | 4.23 | +23.32% | $11.16M | vs BON |
| NAIINatural Alternatives International Inc. | 0.876 | -2.67% | $5.48M | vs BON |
| MTEXMannatech Incorporated | 2.56 | +5.13% | $4.94M | vs BON |
| XXII22nd Century Group Inc. | 0.3365 | -15.43% | $1.08M | vs BON |
| IMCCIM Cannabis Corp. | 0.4999 | +7.23% | $307.30K | vs BON |
| BTMDBiote Corp. Class A | 0.8147 | -3.56% | $26.28M | vs BON |
| FTLFFitLife Brands Inc. | 6.20 | -7.46% | $58.22M | vs BON |
| ISPRIspire Technology Inc. | 1.23 | -3.15% | $71.05M | vs BON |
Indexes, lists and sector
Bon Natural Life stock FAQ
What is Bon Natural Life's stock price today?
BON last traded at $1.04 as of Nov 20, 4:00 PM EST, down 0.50% on the day. Prices are delayed at least 15 minutes.
Who is Bon Natural Life's CEO?
Mr. Yongwei Hu is the chief executive officer of Bon Natural Life Limited Class A, which has about 96 employees.
What is the BON 52-week high?
The 52-week high for BON is $1.94 and the 52-week low is $0.95. The stock is currently 46.1% below its high.